 Iovance Biotherapeutics, Inc. NASDAQ:IOVA Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sara Pellegrino - Senior Vice President, Investor Public Relations Corporate Communications Fred Vogt - Interim President Chief Executive Officer Igor Bilinsky - Chief Operating Officer Jim Ziegler - Executive Vice President, Commercial Friedrich Finckenstein - Chief Medical Officer Jean-Marc Bellemin - Chief Financial Officer Conference Call Participants Peter Lawson - Barclays Dennis Ding - Jefferies Tyler Van Buren - Cowen Reni Benjamin - JMP Securities Mark Breidenbach - Oppenheimer Mara Goldstein - Mizuho Ben Burnett - Stifel Colleen Kusy - Baird Joe Catanzaro - Piper Sandler Operator Welcome to the Iovance Biotherapeutics Second Quarter and First Half 2022 Financial Results and Corporate Update Conference Call. My name is Andrew, and I will be your operator for todays call. 